How is Haleon - the spin-off from GSK plc - getting on?
A busy day on the London market, but I will write about the consumer health company Haleon (HLN), which many of you will remember split out from GSK (GSK) back in July last year. Whilst its shares remain above the level when I last wrote about it in November last year, the stock is down 4% today despite apparently having an "extraordinary year” as being the “first listed company 100% invested” in its specific space.
- By Chris Bailey
- 2023-03-02 12:49:48